We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.

NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray bottle (77112)

ARTG ID 77112

ARTG Name

NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray bottle

Product name

NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray

ARTG Date

14 February 2001

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

mometasone furoate

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

Related information

NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray bottle, ORGANON PHARMA PTY LTD, CON-1408

15 September 2025

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 15 September 2025 until 10 November 2026.
NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray bottle, Organon Pharma Pty Ltd, CON-882

9 November 2021

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective for all batches of the products released from the 9 November 2021 until 30 June 2022.
NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray bottle, Organon Pharma PTY LTD, CON-973

26 July 2022

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective from 26 July 2022 until 30 November 2022 or until the relevant batch/es are exhausted.

Is there anything wrong with this page?

Help us improve